INTRODUCTION
Cyclosporin A (CsA) is an immunosuppressive drug known to influence the development of thymocytes. At a molecular level, CsA target sites have been identified as cyclophilin and calcineurin (Fischer et al., 1989; Takahashi et al., 1989; Liu et al., 1991;  Clipstone and Crabtree, 1992; O'Keefe et al., 1992) . Their significance at stages of T-cell development, however, remains to be determined. Nevertheless, treatment with CsA presents a useful tool with which to dissect normal thymocyte development. Studying the effect on thymocytes at a single time point after long-term GsA treatment has identified subsets that are downstream of CsA-sensitive populations and the extent to which they are sensitive. Most conspicuously, the development of mature SP thymocytes is greatly inhibited (Gao et al., 1988; Jenkins et al., 1989) medulla (Kai and Franklin, 1983; Kanariou et al., 1989) .
It is reported that thymocytes bearing T-cell receptor V]/-segments (TCRs) reactive with selfsuperantigens become detectable amongst mature thymocytes (Gao et al., 1988; Jenkins et al., 1989) , and in the periphery (Urdahl et al., 1992) , where they could potentially mediate an autoimmune response. Such cells (Abe et al., 1988; MacDonald et al., 1988; Pullen et al., 1988) are normally eliminated by clonal deletion during thymic development (Kappler et al., 1987; Fry et al., 1989; Hodes et al., 1989; Schwartz, 1989) , preventing their maturation and entry into the medulla (Hengartner et al., 1988; Sha et al., 1988; Hugo et al., 1991a) . Clonal deletion is effected via apoptosis (Jenkinson et al., 1989) , which is typified by morphological changes, and fragmentation of genomic DNA into multimers of --180 base-pair units (Wyllie et al., 1984) . Immature thymocytes undergoing apoptosis additionally down regulate expression of CD4 and CD8, but retain an intact cell membrane, thereby forming a population that can be identified by flow cytometry 118 R.D.J. HUBY et al. (Swat et al., 1991a (Swat et al., , 1991b and followed using TCR-V]/-specific antibodies (Huby and Goff, manu- script in preparation).
Experimentally, a condition similar to graftversus-host disease can be initiated in young rats (Glazier et al., 1983; Hess et al., 1985) or mice (Cheney and Sprent, 1983; Bryson et al., 1989; Sakaguchi and Sakaguchi, 1989 ) by treating them with CsA after lethal irradiation and bone marrow reconstitution, and then withdrawing the drug. The disease can be initiated in secondary irradiated hosts by the transfer of peripheral T cells or thymocytes from these animals (Sorokin et al., 1986; Beschorner et al., 1988a) , or from the thymus of nonirradiated but CsA-treated donors (Sakaguchi and Sakaguchi, 1988) . This suggests that CsA induces the generation of autoreactive thymocytes that are exported to the periphery while the drug is still being administered (Wodzig et al., 1991) and can initiate an autoimmune reaction when it is withdrawn. The cells responsible for such CsA-induced autoimmunity are likely to be polyclonal, and directed toward true self-antigens conventionally presented by MHC. In contrast, superantigen-reactive cells express specific TCR-V]/ segments that recognize superantigen bound to MHC class II outside the antigen-binding groove (Dellabona et al., 1990; Choi et al., 1992) . The latter are attractively simple to study, although their behavior may not necessarily reflect that of conventional antigen-responsive cells.
It has been speculated that the inhibition of mature thymocyte development occurs during the CD4 CD8 (double-positive) stage; however, by observing subsets at a single time point after CsA treatment, it is not possible to confirm this. We have studied the kinetics of thymocyte subsets in the presence of CsA, using three-color flow cytometry as a means of pinpointing multiple stages of thymocyte development. In addition, three-color flow cytometry in this study has enabled the fate of TCR-V83 / thymocytes to be followed, these cells normally being subject to deletion by BALB/c mice (Abe et al., 1988; MacDonald et al., 1988; Pullen, et al., 1988) .
A kinetic study not only allows CsA-sensitive subsets to be identified, but also reveals the time taken for a subset to develop from its CsA-sensitive precursor (Fig. 1, point a) . Thus, the faster a subset is derived from a CsA-sensitive precursor, the more rapidly it will be lost during treatment. In addition, the initial rate at which a subset is lost, once its immediate precursor has been blocked, will be equal to the rate of flux into that subset (Fig. 1, point b) . Heterogeneity of the subset will be reflected by a nonlinear loss of cells with time ( Fig. 1 (Goff and Huby, 1992 (Fig. 2) . Further subsetting was possible by detecting CD3 as a third color parameter. Numbers of CD4-CD8-CD3-(triple-negative) and CD4-CD8-intermediates were moderately and slowly reduced during treatment, suggesting that intrathymic precursors with limited capacity for self-renewal were partially depleted over the period of the experiment (Fig. 3a) . Nevertheless, numbers of their CD4 / CD8
/ progeny fell by ---50% within 4 days to a level that was subsequently maintained (Fig. 3b) (Fig. 4) . Consistent with this analysis, the CD4 SPs, but not CD8 SPs were discrete from the CD4 / CD8 / subset after 2 days of CsA treatment (cf. Fig. 3c ). The CD8 SP subset was discrete by day 7, before the numbers of CD8 / CD45RA
/ thymocytes had started to decline (Fig. 3d) , indicating that the latter were not directly derived from this DP subset.
CsA Inhibits the Apoptosis of Autoreactive Thymocytes Immature thymocytes undergoing apoptosis downregulate CD4 and CD8 expression (Swat et al., 1991a (Swat et al., , 1991b regulation of CD8 among developing thymocytes corresponding to a greater level of maturity; the up-regulating TCR-V/3 was reduced by 62% overall fraction of cells with a CD4dimCD8 dim phe-(p-0.012), and that corresponding to down-notype was therefore unaffected (Fig. 5) . regulation of CD4 by 30% (p 0.005) (Fig. 5 and 6 ). Similar results were seen for as long as CsA was Mature Autoreactive Thymocytes Fail to given (Fig. 6) , and that intrathymic prothymocytes have a large but limited capacity for self-renewal (Frey et al., 1992) . CD4 CD8 CD3 / thymocytes, thought to constitute a side lineage with a slow turnover (Egerton et al., 1990 ) and a CsA-sensitive precursor (Takahama et al., 1991) , declined with very similar kinetics to CD4-CD8-CD3-thymocytes (unpublished data).
In BALB/c mice, about 50% of the CD4 / CD8 subset was lost within 4 days of commencing CsA treatment, primarily accounting for a similar loss of thymic weight over the same period. Placeboinjected controls were essentially unaffected (data not shown). Within the CD4 / CD8 / subset, the CD3 high fraction underwent very rapid depletion, falling to minimal levels within 2 days. Such a rapid decline indicates that this subset is very transient, as described elsewhere (Hugo et al., 1991b) (Huby and Goff, 1992) . They represent an additional subset when they are present (Goff and Huby, 1992) (Cheney and Sprent 1983; Glazier et al., 1983; Hess et al., 1985) . Autoreactive T cells can be found in the thymus of diseased animals (Beschomer et al., 1988b) , where they are presumably generated during CsA treatment, because prior thymectomy is protective (Sorokin et al., 1986) . The aetiology of the disease, however, may depend critically upon the destruction of thymic medullary stroma initiated by CsA-induced cytotoxic T cells (Beschomer et al., 1988b) ; T cells capable of recognizing self-superantigens (Kappler et al., 1987 have been found in the thymus (Gao et al., 1988; Jenkins et al., 1989) (Shi et al., 1989) , the major mechanism whereby clonal deletion is achieved (Jenkinson et al., 1989) . Using a flow cytometric method (Swat et al., 1991a (Swat et al., , 1991b (Fischer et al., 1989; Takahashi et al., 1989; Liu et al., 1991) . It remains to be determined why CsA blocks thymocyte differentiation at such specific points of development, although linkage to a requirement for TCR stimulation is emerging as a possible common theme.
